{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T13:16:14Z","timestamp":1788441374869,"version":"build-2803163510"},"reference-count":113,"publisher":"IMR Press","issue":"8","license":[{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Biosci. (Landmark Ed)"],"abstract":"<jats:p>Traumatic brain injury (TBI) is characterized by a \u201ctranslational paradox\u201d, where robust preclinical successes rarely achieve clinical efficacy. This review provides a critical appraisal of emerging therapeutics, moving beyond traditional silos to propose a unified, stage-dependent roadmap for neurorestoration. Reflecting on translational insights from past trials, specifically the limitations of standardized timing and phenotypic heterogeneity, we introduce the \u201cTemporal Precision Medicine\u201d framework. Central to this synthesis is the Dual-Axis Theory, which posits that successful emerging modalities, including repurposed agents such as glibenclamide, amantadine, and statins, alongside cell-free biologics and neuromodulation, converge on two shared pathological targets: the Inflammatory Axis (M1-to-M2 microglial polarization) and the Metabolic Axis (restoration of mitochondrial bioenergetics). We operationalize these biological insights into a Triple-Axis Framework, a dynamic clinical roadmap that aligns stage-dependent interventions with phase-specific biomarkers and pathological mechanisms. By integrating these biological signals with bioengineered delivery systems and artificial intelligence (AI)-driven precision phenotyping, the field can transition from acute neuroprotection toward genuine circuit-level regeneration. We conclude with a blueprint for the next generation of TBI trials, emphasizing biomarker-based stratification and multidimensional endpoints to bridge the translational gap.<\/jats:p>","DOI":"10.31083\/fbl48402","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T12:35:31Z","timestamp":1788438931000},"source":"Crossref","is-referenced-by-count":0,"title":["Mechanism-Targeted Therapeutic Strategies for Traumatic Brain Injury: From Molecular Pathways to Functional Recovery"],"prefix":"10.31083","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1816-6194","authenticated-orcid":true,"given":"Ana","family":"Costa","sequence":"first","affiliation":[{"name":"Department of Anesthesiology, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY 11794, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Davidson","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY 11794, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emiliya","family":"Rakhamimova","sequence":"additional","affiliation":[{"name":"Renaissance School of Medicine, Stony Brook University, Stony Brook, NY 11794, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Bartula","sequence":"additional","affiliation":[{"name":"Renaissance School of Medicine, Stony Brook University, Stony Brook, NY 11794, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Geralemou","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY 11794, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidong","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY 11794, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5641-5908","authenticated-orcid":true,"given":"Sergio D.","family":"Bergese","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY 11794, USA"},{"name":"Department of Neurosurgery, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY 11794, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16242","published-online":{"date-parts":[[2026,8,18]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Maas AIR, Menon DK, Manley GT, Abrams M, \u00c5kerlund C, Andelic N, et al. Traumatic brain injury: progress and challenges in prevention, clinical care, and research. The Lancet. Neurology. 2022; 21: 1004\u20131060.","DOI":"10.1016\/S1474-4422(22)00309-X"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Weil ZM, Karelina K. Lifelong consequences of brain injuries during development: From risk to resilience. Frontiers in Neuroendocrinology. 2019; 55: 100793.","DOI":"10.1016\/j.yfrne.2019.100793"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Sandsmark DK. Clinical Outcomes after Traumatic Brain Injury. Current Neurology and Neuroscience Reports. 2016; 16: 52.","DOI":"10.1007\/s11910-016-0654-5"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Guan B, Anderson DB, Chen L, Feng S, Zhou H. Global, regional and national burden of traumatic brain injury and spinal cord injury, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. BMJ Open. 2023; 13: e075049.","DOI":"10.1136\/bmjopen-2023-075049"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Masel BE, DeWitt DS. Traumatic brain injury: a disease process, not an event. Journal of Neurotrauma. 2010; 27: 1529\u20131540.","DOI":"10.1089\/neu.2010.1358"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Blennow K, Brody DL, Kochanek PM, Levin H, McKee A, Ribbers GM, et al. Traumatic brain injuries. Nature Reviews. Disease Primers. 2016; 2: 16084.","DOI":"10.1038\/nrdp.2016.84"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Capizzi A, Woo J, Verduzco-Gutierrez M. Traumatic Brain Injury: An Overview of Epidemiology, Pathophysiology, and Medical Management. The Medical Clinics of North America. 2020; 104: 213\u2013238.","DOI":"10.1016\/j.mcna.2019.11.001"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Lamade AM, Anthonymuthu TS, Hier ZE, Gao Y, Kagan VE, Bay\u0131r H. Mitochondrial damage & lipid signaling in traumatic brain injury. Experimental Neurology. 2020; 329: 113307.","DOI":"10.1016\/j.expneurol.2020.113307"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Freire MAM, Rocha GS, Bittencourt LO, Falcao D, Lima RR, Cavalcanti JRLP. Cellular and Molecular Pathophysiology of Traumatic Brain Injury: What Have We Learned So Far? Biology. 2023; 12: 1139.","DOI":"10.3390\/biology12081139"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Ghiam MK, Patel SD, Hoffer A, Selman WR, Hoffer BJ, Hoffer ME. Drug Repurposing in the Treatment of Traumatic Brain Injury. Frontiers in Neuroscience. 2021; 15: 635483.","DOI":"10.3389\/fnins.2021.635483"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Loane DJ, Faden AI. Neuroprotection for traumatic brain injury: translational challenges and emerging therapeutic strategies. Trends in Pharmacological Sciences. 2010; 31: 596\u2013604.","DOI":"10.1016\/j.tips.2010.09.005"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Cheong S, Gupta R, Kadaba Sridhar S, Hall AJ, Frankel M, Wright DW, et al. Progesterone for Traumatic Brain Injury, Experimental Clinical Treatment III Trial Revisited: Objective Classification of Traumatic Brain Injury With Brain Imaging Segmentation and Biomarker Levels. Critical Care Explorations. 2025; 7: e1306.","DOI":"10.1097\/CCE.0000000000001306"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Frangogiannis NG. Why animal model studies are lost in translation. The Journal of Cardiovascular Aging. 2022; 2: 22.","DOI":"10.20517\/jca.2022.10"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Lynch DG, Narayan RK, Li C. Multi-Mechanistic Approaches to the Treatment of Traumatic Brain Injury: A Review. Journal of Clinical Medicine. 2023; 12: 2179.","DOI":"10.3390\/jcm12062179"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Conklin J, Lev MH. A New Multimodal Classification and Nomenclature System for Acute Traumatic Brain Injury From the NIH-NINDS. AJR. American Journal of Roentgenology. 2025; 225: e2533684.","DOI":"10.2214\/AJR.25.33684"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Hawryluk GWJ, Rubiano AM, Totten AM, O'Reilly C, Ullman JS, Bratton SL, et al. Guidelines for the Management of Severe Traumatic Brain Injury: 2020 Update of the Decompressive Craniectomy Recommendations. Neurosurgery. 2020; 87: 427\u2013434.","DOI":"10.1093\/neuros\/nyaa278"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Schizodimos T, Soulountsi V, Iasonidou C, Kapravelos N. An overview of management of intracranial hypertension in the intensive care unit. Journal of Anesthesia. 2020; 34: 741\u2013757.","DOI":"10.1007\/s00540-020-02795-7"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Sharma R, Tsikvadze M, Peel J, Howard L, Kapoor N, Freeman WD. Multimodal monitoring: practical recommendations (dos and don'ts) in challenging situations and uncertainty. Frontiers in Neurology. 2023; 14: 1135406.","DOI":"10.3389\/fneur.2023.1135406"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Szeleszczuk \u0141, Fr\u0105czkowski D. Propranolol versus Other Selected Drugs in the Treatment of Various Types of Anxiety or Stress, with Particular Reference to Stage Fright and Post-Traumatic Stress Disorder. International Journal of Molecular Sciences. 2022; 23: 10099.","DOI":"10.3390\/ijms231710099"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Khalili H, Ahl R, Paydar S, Sjolin G, Cao Y, Abdolrahimzadeh Fard H, et al. Beta-Blocker Therapy in Severe Traumatic Brain Injury: A Prospective Randomized Controlled Trial. World Journal of Surgery. 2020; 44: 1844\u20131853.","DOI":"10.1007\/s00268-020-05391-8"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Sivandzade F, Alqahtani F, Cucullo L. Traumatic Brain Injury and Blood-Brain Barrier (BBB): Underlying Pathophysiological Mechanisms and the Influence of Cigarette Smoking as a Premorbid Condition. International Journal of Molecular Sciences. 2020; 21: 2721.","DOI":"10.3390\/ijms21082721"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Cutler SM, Cekic M, Miller DM, Wali B, VanLandingham JW, Stein DG. Progesterone improves acute recovery after traumatic brain injury in the aged rat. Journal of Neurotrauma. 2007; 24: 1475\u20131486.","DOI":"10.1089\/neu.2007.0294"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Giordano KR, Saber M, Green TRF, Rojas-Valencia LM, Ortiz JB, Murphy SM, et al. Colony-Stimulating Factor-1 Receptor Inhibition Transiently Attenuated the Peripheral Immune Response to Experimental Traumatic Brain Injury. Neurotrauma Reports. 2023; 4: 284\u2013296.","DOI":"10.1089\/neur.2022.0092"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Marino Lee S, Hudobenko J, McCullough LD, Chauhan A. Microglia depletion increase brain injury after acute ischemic stroke in aged mice. Experimental Neurology. 2021; 336: 113530.","DOI":"10.1016\/j.expneurol.2020.113530"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Liu Y, Zeng R, Wang Y, Huang W, Hu B, Zhu G, et al. Mesenchymal stem cells enhance microglia M2 polarization and attenuate neuroinflammation through TSG-6. Brain Research. 2019; 1724: 146422.","DOI":"10.1016\/j.brainres.2019.146422"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Bagheri H, Ghasemi F, Barreto GE, Sathyapalan T, Jamialahmadi T, Sahebkar A. The effects of statins on microglial cells to protect against neurodegenerative disorders: A mechanistic review. BioFactors (Oxford, England). 2020; 46: 309\u2013325.","DOI":"10.1002\/biof.1597"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Lucke-Wold BP, Turner RC, Logsdon AF, Bailes JE, Huber JD, Rosen CL. Linking traumatic brain injury to chronic traumatic encephalopathy: identification of potential mechanisms leading to neurofibrillary tangle development. Journal of Neurotrauma. 2014; 31: 1129\u20131138.","DOI":"10.1089\/neu.2013.3303"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Hamblin MR. Photobiomodulation for traumatic brain injury and stroke. Journal of Neuroscience Research. 2018; 96: 731\u2013743.","DOI":"10.1002\/jnr.24190"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Philip NS, Ramanathan D, Gamboa B, Brennan MC, Kozel FA, Lazzeroni L, et al. Repetitive Transcranial Magnetic Stimulation for Depression and Posttraumatic Stress Disorder in Veterans With Mild Traumatic Brain Injury. Neuromodulation : Journal of the International Neuromodulation Society. 2023; 26: 878\u2013884.","DOI":"10.1016\/j.neurom.2022.11.015"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Naji A, Eitoku M, Favier B, Deschaseaux F, Rouas-Freiss N, Suganuma N. Biological functions of mesenchymal stem cells and clinical implications. Cellular and Molecular Life Sciences : CMLS. 2019; 76: 3323\u20133348.","DOI":"10.1007\/s00018-019-03125-1"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Gupta A, Singh S. Potential Role of Growth Factors Controlled Release in Achieving Enhanced Neuronal Trans-differentiation from Mesenchymal Stem Cells for Neural Tissue Repair and Regeneration. Molecular Neurobiology. 2022; 59: 983\u20131001.","DOI":"10.1007\/s12035-021-02646-w"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Delila L, Nebie O, Le NTN, Timmerman K, Lee DY, Wu YW, et al. Neuroprotective effects of intranasal extracellular vesicles from human platelet concentrates supernatants in traumatic brain injury and Parkinson's disease models. Journal of Biomedical Science. 2024; 31: 87.","DOI":"10.1186\/s12929-024-01072-z"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Wang J, Xia J, Huang R, Hu Y, Fan J, Shu Q, et al. Mesenchymal stem cell-derived extracellular vesicles alter disease outcomes via endorsement of macrophage polarization. Stem Cell Research & Therapy. 2020; 11: 424.","DOI":"10.1186\/s13287-020-01937-8"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Liu X, Wei Q, Lu L, Cui S, Ma K, Zhang W, et al. Immunomodulatory potential of mesenchymal stem cell-derived extracellular vesicles: Targeting immune cells. Frontiers in Immunology. 2023; 14: 1094685.","DOI":"10.3389\/fimmu.2023.1094685"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"Terada K, Sasaki M, Nagahama H, Kataoka-Sasaki Y, Oka S, Ukai R, et al. Therapeutic efficacy of intravenous infusion of mesenchymal stem cells in rat perinatal brain injury. Pediatric Research. 2023; 94: 1921\u20131928.","DOI":"10.1038\/s41390-023-02717-9"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Mohamed GA, Lench DH, Grewal P, Rosenberg M, Voeks J. Stem cell therapy: a new hope for stroke and traumatic brain injury recovery and the challenge for rural minorities in South Carolina. Frontiers in Neurology. 2024; 15: 1419867.","DOI":"10.3389\/fneur.2024.1419867"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"Ferrini E, Stellari FF, Franceschi V, Macchi F, Russo L, Murgia A, et al. Persistency of Mesenchymal Stromal\/Stem Cells in Lungs. Frontiers in Cell and Developmental Biology. 2021; 9: 709225.","DOI":"10.3389\/fcell.2021.709225"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"Zanier ER, Pischiutta F, Rulli E, Vargiolu A, Elli F, Gritti P, et al. MesenchymAl stromal cells for Traumatic bRain Injury (MATRIx): a study protocol for a multicenter, double-blind, randomised, placebo-controlled phase II trial. Intensive Care Medicine Experimental. 2023; 11: 56.","DOI":"10.1186\/s40635-023-00535-1"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"Cox CS Jr, Notrica DM, Juranek J, Miller JH, Triolo F, Kosmach S, et al. Autologous bone marrow mononuclear cells to treat severe traumatic brain injury in children. Brain : a Journal of Neurology. 2024; 147: 1914\u20131925.","DOI":"10.1093\/brain\/awae005"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"Wang J, Fu X, Jiang C, Yu L, Wang M, Han W, et al. Bone marrow mononuclear cell transplantation promotes therapeutic angiogenesis via upregulation of the VEGF-VEGFR2 signaling pathway in a rat model of vascular dementia. Behavioural Brain Research. 2014; 265: 171\u2013180.","DOI":"10.1016\/j.bbr.2014.02.033"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"Bou Najm D, Alame S. Therapeutic potential of stem cells in pediatric neurology: Insights from clinical trials. Neuroprotection (Chichester, England). 2025; 3: 303\u2013321.","DOI":"10.1002\/nep3.70022"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"Weber RZ, Rust R, Tackenberg C. How neural stem cell therapy promotes brain repair after stroke. Stem Cell Reports. 2025; 20: 102507.","DOI":"10.1016\/j.stemcr.2025.102507"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"Li X, Sundstr\u00f6m E. Stem Cell Therapies for Central Nervous System Trauma: The 4 Ws-What, When, Where, and Why. Stem Cells Translational Medicine. 2022; 11: 14\u201325.","DOI":"10.1093\/stcltm\/szab006"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"Yang Y, Hu X, Qin Q, Kong F, Peng X, Zhao J, et al. Optimal therapeutic conditions for the neural stem cell-based management of ischemic stroke: a systematic review and network meta-analysis based on animal studies. BMC Neurology. 2022; 22: 345.","DOI":"10.1186\/s12883-022-02875-z"},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"Chen J, Chopp M. Exosome Therapy for Stroke. Stroke. 2018; 49: 1083\u20131090.","DOI":"10.1161\/STROKEAHA.117.018292"},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science (New York, N.Y.). 2020; 367: eaau6977.","DOI":"10.1126\/science.aau6977"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"Dong X, Dong JF, Zhang J. Roles and therapeutic potential of different extracellular vesicle subtypes on traumatic brain injury. Cell Communication and Signaling : CCS. 2023; 21: 211.","DOI":"10.1186\/s12964-023-01165-6"},{"key":"ref48","doi-asserted-by":"publisher","unstructured":"Yarahmadi A, Dorri Giv M, Hosseininejad R, Rezaie A, Mohammadi N, Afkhami H, et al. Mesenchymal stem cells and their extracellular vesicle therapy for neurological disorders: traumatic brain injury and beyond. Frontiers in Neurology. 2025; 16: 1472679.","DOI":"10.3389\/fneur.2025.1472679"},{"key":"ref49","doi-asserted-by":"publisher","unstructured":"Li P, Sun S, Zhu X, Liu X, Yin R, Chen Y, et al. Intranasal delivery of engineered extracellular vesicles promotes neurofunctional recovery in traumatic brain injury. Journal of Nanobiotechnology. 2025; 23: 229.","DOI":"10.1186\/s12951-025-03181-9"},{"key":"ref50","doi-asserted-by":"publisher","unstructured":"Che Shaffi S, Hairuddin ON, Mansor SF, Syafiq TMF, Yahaya BH. Unlocking the Potential of Extracellular Vesicles as the Next Generation Therapy: Challenges and Opportunities. Tissue Engineering and Regenerative Medicine. 2024; 21: 513\u2013527.","DOI":"10.1007\/s13770-024-00634-4"},{"key":"ref51","doi-asserted-by":"publisher","unstructured":"Chen L, Xiong Y, Chopp M, Zhang Y. Engineered exosomes enriched with select microRNAs amplify their therapeutic efficacy for traumatic brain injury and stroke. Frontiers in Cellular Neuroscience. 2024; 18: 1376601.","DOI":"10.3389\/fncel.2024.1376601"},{"key":"ref52","doi-asserted-by":"publisher","unstructured":"Sultan W, Sapkota A, Khurshid H, Qureshi IA, Jahan N, Went TR, et al. Statins' Effect on Cognitive Outcome After Traumatic Brain Injury: A Systematic Review. Cureus. 2021; 13: e16953.","DOI":"10.7759\/cureus.16953"},{"key":"ref53","doi-asserted-by":"publisher","unstructured":"S\u00e1nchez-Aguilar M, Tapia-P\u00e9rez JH, S\u00e1nchez-Rodr\u00edguez JJ, Vi\u00f1as-R\u00edos JM, Mart\u00ednez-P\u00e9rez P, de la Cruz-Mendoza E, et al. Effect of rosuvastatin on cytokines after traumatic head injury. Journal of Neurosurgery. 2013; 118: 669\u2013675.","DOI":"10.3171\/2012.12.JNS121084"},{"key":"ref54","doi-asserted-by":"publisher","unstructured":"Susanto M, Pangihutan Siahaan AM, Wirjomartani BA, Setiawan H, Aryanti C, Michael. The neuroprotective effect of statin in traumatic brain injury: A systematic review. World Neurosurgery: X. 2023; 19: 100211.","DOI":"10.1016\/j.wnsx.2023.100211"},{"key":"ref55","unstructured":"University of California SF. Multi-Arm Multi-Stage Adaptive Platform Trial (APT) for the Acute Treatment of Traumatic Brain Injury (APT-TBI-01). NLM identifier: NCT05826912. 2023. Available at: https:\/\/clinicaltrials.gov\/study\/NCT05826912 (Accessed: 15 February 2026)."},{"key":"ref56","doi-asserted-by":"publisher","unstructured":"Underwood EL, Redell JB, Maynard ME, Kobori N, Hylin MJ, Hood KN, et al. Metformin Reduces Repeat Mild Concussive Injury Pathophysiology. eneuro. 2022; 9: ENEURO.0421\u201321.2021.","DOI":"10.1523\/ENEURO.0421-21.2021"},{"key":"ref57","doi-asserted-by":"publisher","unstructured":"Fan YY, Wang YJ, Guo J, Wu MN, Zhang MS, Niu BL, et al. Delayed metformin treatment improves functional recovery following traumatic brain injury via central AMPK-dependent brain tissue repair. Brain Research Bulletin. 2020; 164: 146\u2013156.","DOI":"10.1016\/j.brainresbull.2020.08.021"},{"key":"ref58","doi-asserted-by":"publisher","unstructured":"Taheri A, Emami M, Asadipour E, Kasirzadeh S, Rouini MR, Najafi A, et al. A randomized controlled trial on the efficacy, safety, and pharmacokinetics of metformin in severe traumatic brain injury. Journal of Neurology. 2019; 266: 1988\u20131997.","DOI":"10.1007\/s00415-019-09366-1"},{"key":"ref59","doi-asserted-by":"publisher","unstructured":"Jha RM, Simard JM. Glibenclamide for Brain Contusions: Contextualizing a Promising Clinical Trial Design that Leverages an Imaging-Based TBI Endotype. Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics. 2023; 20: 1472\u20131481.","DOI":"10.1007\/s13311-023-01389-x"},{"key":"ref60","doi-asserted-by":"publisher","unstructured":"Jha RM, Bell J, Citerio G, Hemphill JC, Kimberly WT, Narayan RK, et al. Role of Sulfonylurea Receptor 1 and Glibenclamide in Traumatic Brain Injury: A Review of the Evidence. International Journal of Molecular Sciences. 2020; 21: 409.","DOI":"10.3390\/ijms21020409"},{"key":"ref61","doi-asserted-by":"publisher","unstructured":"Jha RM, Mondello S, Bramlett HM, Dixon CE, Shear DA, Dietrich WD, et al. Glibenclamide Treatment in Traumatic Brain Injury: Operation Brain Trauma Therapy. Journal of Neurotrauma. 2021; 38: 628\u2013645.","DOI":"10.1089\/neu.2020.7421"},{"key":"ref62","unstructured":"Remedy Pharmaceuticals I. A Multicenter, Double-Blind, Multidose, Placebo-Controlled, Randomized, Parallel-Group, Phase 2 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 for Patients With Brain Contusion. NLM identifier: NCT03954041. 2019. Available at: https:\/\/clinicaltrials.gov\/study\/NCT03954041 (Accessed: 15 February 2026)."},{"key":"ref63","doi-asserted-by":"publisher","unstructured":"Ossola B, Schendzielorz N, Chen SH, Bird GS, Tuominen RK, M\u00e4nnist\u00f6 PT, et al. Amantadine protects dopamine neurons by a dual action: reducing activation of microglia and inducing expression of GDNF in astroglia [corrected]. Neuropharmacology. 2011; 61: 574\u2013582.","DOI":"10.1016\/j.neuropharm.2011.04.030"},{"key":"ref64","doi-asserted-by":"publisher","unstructured":"Dekundy A, Pichler G, El Badry R, Scheschonka A, Danysz W. Amantadine for Traumatic Brain Injury-Supporting Evidence and Mode of Action. Biomedicines. 2024; 12: 1558.","DOI":"10.3390\/biomedicines12071558"},{"key":"ref65","doi-asserted-by":"publisher","unstructured":"Hadgu RM, Borghol A, Gillard C, Wilson C, Elqess Mossa S, McKay M, et al. Evaluation of Outcomes in Patients Receiving Amantadine to Improve Alertness After Traumatic Brain Injury. Hospital Pharmacy. 2021; 56: 486\u2013494.","DOI":"10.1177\/0018578720920803"},{"key":"ref66","doi-asserted-by":"publisher","unstructured":"Loggini A, Tangonan R, El Ammar F, Mansour A, Goldenberg FD, Kramer CL, et al. The role of amantadine in cognitive recovery early after traumatic brain injury: A systematic review. Clinical Neurology and Neurosurgery. 2020; 194: 105815.","DOI":"10.1016\/j.clineuro.2020.105815"},{"key":"ref67","unstructured":"SHINKEI Therapeutics I. Multicenter, Double-blind, Randomized, Placebo Controlled, Study to Assess the Safety of Amantadine Hydrochloride (HCl) Intravenous (IV) Solution (MR-301), in Patients With Severe Traumatic Brain Injury (TBI). NLM identifier: NCT06253923. 2024. Available at: https:\/\/clinicaltrials.gov\/study\/NCT06253923 (Accessed: 15 February 2026)."},{"key":"ref68","doi-asserted-by":"publisher","unstructured":"Rodrigues PA, Zaninotto AL, Ventresca HM, Neville IS, Hayashi CY, Brunoni AR, et al. The Effects of Repetitive Transcranial Magnetic Stimulation on Anxiety in Patients With Moderate to Severe Traumatic Brain Injury: A Post-hoc Analysis of a Randomized Clinical Trial. Frontiers in Neurology. 2020; 11: 564940.","DOI":"10.3389\/fneur.2020.564940"},{"key":"ref69","doi-asserted-by":"publisher","unstructured":"Chan ST, Mercaldo N, Figueiro Longo MG, Welt J, Avesta A, Lee J, et al. Effects of Low-Level Light Therapy on Resting-State Connectivity Following Moderate Traumatic Brain Injury: Secondary Analyses of a Double-blinded Placebo-controlled Study. Radiology. 2024; 311: e230999.","DOI":"10.1148\/radiol.230999"},{"key":"ref70","doi-asserted-by":"publisher","unstructured":"Hipskind SG, Grover FL Jr, Fort TR, Helffenstein D, Burke TJ, Quint SA, et al. Pulsed Transcranial Red\/Near-Infrared Light Therapy Using Light-Emitting Diodes Improves Cerebral Blood Flow and Cognitive Function in Veterans with Chronic Traumatic Brain Injury: A Case Series. Photobiomodulation, Photomedicine, and Laser Surgery. 2019; 37: 77\u201384.","DOI":"10.1089\/photob.2018.4489"},{"key":"ref71","doi-asserted-by":"publisher","unstructured":"Lim L. Traumatic Brain Injury Recovery with Photobiomodulation: Cellular Mechanisms, Clinical Evidence, and Future Potential. Cells. 2024; 13: 385.","DOI":"10.3390\/cells13050385"},{"key":"ref72","doi-asserted-by":"publisher","unstructured":"Wu D, Chen Q, Chen X, Han F, Chen Z, Wang Y. The blood-brain barrier: structure, regulation, and drug delivery. Signal Transduction and Targeted Therapy. 2023; 8: 217.","DOI":"10.1038\/s41392-023-01481-w"},{"key":"ref73","doi-asserted-by":"publisher","unstructured":"Lei K, Zhou L, Dan M, Yang F, Jian T, Xin J, et al. Trojan Horse Delivery Strategies of Natural Medicine Monomers: Challenges and Limitations in Improving Brain Targeting. Pharmaceutics. 2025; 17: 280.","DOI":"10.3390\/pharmaceutics17030280"},{"key":"ref74","doi-asserted-by":"publisher","unstructured":"Romero-Ben E, Goswami U, Soto-Cruz J, Mansoori-Kermani A, Mishra D, Martin-Salda\u00f1a S, et al. Polymer-based nanocarriers to transport therapeutic biomacromolecules across the blood-brain barrier. Acta Biomaterialia. 2025; 196: 17\u201349.","DOI":"10.1016\/j.actbio.2025.02.065"},{"key":"ref75","doi-asserted-by":"publisher","unstructured":"Xuan L, Ju Z, Skonieczna M, Zhou PK, Huang R. Nanoparticles-induced potential toxicity on human health: Applications, toxicity mechanisms, and evaluation models. MedComm. 2023; 4: e327.","DOI":"10.1002\/mco2.327"},{"key":"ref76","doi-asserted-by":"publisher","unstructured":"Aqel S, Al-Thani N, Haider MZ, Abdelhady S, Al Thani AA, Kobeissy F, et al. Biomaterials in Traumatic Brain Injury: Perspectives and Challenges. Biology. 2023; 13: 21.","DOI":"10.3390\/biology13010021"},{"key":"ref77","doi-asserted-by":"publisher","unstructured":"Sarma S, Deka DJ, Rajak P, Laloo D, Das T, Chetia P, et al. Potential injectable hydrogels as biomaterials for central nervous system injury: A narrative review. Ibrain. 2023; 9: 402\u2013420.","DOI":"10.1002\/ibra.12137"},{"key":"ref78","doi-asserted-by":"publisher","unstructured":"Chen T, Xia Y, Zhang L, Xu T, Yi Y, Chen J, et al. Loading neural stem cells on hydrogel scaffold improves cell retention rate and promotes functional recovery in traumatic brain injury. Materials Today. Bio. 2023; 19: 100606.","DOI":"10.1016\/j.mtbio.2023.100606"},{"key":"ref79","doi-asserted-by":"publisher","unstructured":"Wu C, Liu A, Chen S, Zhang X, Chen L, Zhu Y, et al. Cell-Laden Electroconductive Hydrogel Simulating Nerve Matrix To Deliver Electrical Cues and Promote Neurogenesis. ACS Applied Materials & Interfaces. 2019; 11: 22152\u201322163.","DOI":"10.1021\/acsami.9b05520"},{"key":"ref80","doi-asserted-by":"publisher","unstructured":"Tr\u0119da C, W\u0142odarczyk A, Rieske P. The hope, hype and obstacles surrounding cell therapy. Journal of Cellular and Molecular Medicine. 2024; 28: e18359.","DOI":"10.1111\/jcmm.18359"},{"key":"ref81","doi-asserted-by":"publisher","unstructured":"Shahror RA, Linares GR, Wang Y, Hsueh SC, Wu CC, Chuang DM, et al. Transplantation of Mesenchymal Stem Cells Overexpressing Fibroblast Growth Factor 21 Facilitates Cognitive Recovery and Enhances Neurogenesis in a Mouse Model of Traumatic Brain Injury. Journal of Neurotrauma. 2020; 37: 14\u201326.","DOI":"10.1089\/neu.2019.6422"},{"key":"ref82","unstructured":"Li X, Zhang J, Zhu X, Wang P, Wang X, Li D. Progesterone reduces inflammation and apoptosis in neonatal rats with hypoxic ischemic brain damage through the PI3K\/Akt pathway. International Journal of Clinical and Experimental Medicine. 2015; 8: 8197\u20138203."},{"key":"ref83","doi-asserted-by":"publisher","unstructured":"Skolnick BE, Maas AI, Narayan RK, van der Hoop RG, MacAllister T, Ward JD, et al. A clinical trial of progesterone for severe traumatic brain injury. The New England Journal of Medicine. 2014; 371: 2467\u20132476.","DOI":"10.1056\/NEJMoa1411090"},{"key":"ref84","doi-asserted-by":"publisher","unstructured":"Ma J, Huang S, Qin S, You C, Zeng Y. Progesterone for acute traumatic brain injury. The Cochrane Database of Systematic Reviews. 2016; 12: CD008409.","DOI":"10.1002\/14651858.CD008409.pub4"},{"key":"ref85","doi-asserted-by":"publisher","unstructured":"Risling M, Smith D, Stein TD, Thelin EP, Zanier ER, Ankarcrona M, et al. Modelling human pathology of traumatic brain injury in animal models. Journal of Internal Medicine. 2019; 285: 594\u2013607.","DOI":"10.1111\/joim.12909"},{"key":"ref86","doi-asserted-by":"publisher","unstructured":"Sunny A, James RR, Menon SR, Rayaroth S, Daniel A, Thompson NA, et al. Matrix Metalloproteinase-9 inhibitors as therapeutic drugs for traumatic brain injury. Neurochemistry International. 2024; 172: 105642.","DOI":"10.1016\/j.neuint.2023.105642"},{"key":"ref87","doi-asserted-by":"publisher","unstructured":"Jones C, Elliott B, Liao Z, Johnson Z, Ma F, Bailey ZS, et al. PEG hydrogel containing dexamethasone-conjugated hyaluronic acid reduces secondary injury and improves motor function in a rat moderate TBI model. Experimental Neurology. 2023; 369: 114533.","DOI":"10.1016\/j.expneurol.2023.114533"},{"key":"ref88","doi-asserted-by":"publisher","unstructured":"Jones CE, Elliott B, Ma F, Bailey Z, Gilsdorf J, Scultetus AH, et al. Point-of-Injury Treatment with Hydrogel Containing Dexamethasone Improves Cognitive Function and Reduces Secondary Injury Response After TBI. Gels (Basel, Switzerland). 2025; 11: 600.","DOI":"10.3390\/gels11080600"},{"key":"ref89","doi-asserted-by":"publisher","unstructured":"Han Y, Weng W, Zhang Y, Feng Q, Ma Y, Quan A, et al. Intraoperative application of intelligent, responsive, self-assembling hydrogel rectifies oxygen and energy metabolism in traumatically injured brain. Biomaterials. 2024; 306: 122495.","DOI":"10.1016\/j.biomaterials.2024.122495"},{"key":"ref90","doi-asserted-by":"publisher","unstructured":"He Z, Zang H, Zhu L, Huang K, Yi T, Zhang S, et al. An anti-inflammatory peptide and brain-derived neurotrophic factor-modified hyaluronan-methylcellulose hydrogel promotes nerve regeneration in rats with spinal cord injury. International Journal of Nanomedicine. 2019; 14: 721\u2013732.","DOI":"10.2147\/IJN.S187854"},{"key":"ref91","doi-asserted-by":"publisher","unstructured":"Shi W, Huang CJ, Xu XD, Jin GH, Huang RQ, Huang JF, et al. Transplantation of RADA16-BDNF peptide scaffold with human umbilical cord mesenchymal stem cells forced with CXCR4 and activated astrocytes for repair of traumatic brain injury. Acta Biomaterialia. 2016; 45: 247\u2013261.","DOI":"10.1016\/j.actbio.2016.09.001"},{"key":"ref92","doi-asserted-by":"publisher","unstructured":"Da Silva K, Kumar P, van Vuuren SF, Pillay V, Choonara YE. Three-Dimensional Printability of an ECM-Based Gelatin Methacryloyl (GelMA) Biomaterial for Potential Neuroregeneration. ACS Omega. 2021; 6: 21368\u201321383.","DOI":"10.1021\/acsomega.1c01903"},{"key":"ref93","doi-asserted-by":"publisher","unstructured":"Li Z, Song P, Li G, Han Y, Ren X, Bai L, et al. AI energized hydrogel design, optimization and application in biomedicine. Materials Today. Bio. 2024; 25: 101014.","DOI":"10.1016\/j.mtbio.2024.101014"},{"key":"ref94","doi-asserted-by":"publisher","unstructured":"Hettick M, Ho E, Poole AJ, Monge M, Papageorgiou D, Takahashi K, et al. The Layer 7 Cortical Interface: A Scalable and Minimally Invasive Brain\u2013Computer Interface Platform. bioRxiv. 2024.  (preprint)","DOI":"10.1101\/2022.01.02.474656"},{"key":"ref95","doi-asserted-by":"publisher","unstructured":"Tonin A, Semprini M, Kiper P, Mantini D. Brain-Computer Interfaces for Stroke Motor Rehabilitation. Bioengineering (Basel, Switzerland). 2025; 12: 820.","DOI":"10.3390\/bioengineering12080820"},{"key":"ref96","doi-asserted-by":"publisher","unstructured":"Popa LL, Chira D, Strilciuc \u0218, Mure\u0219anu DF. Non-Invasive Systems Application in Traumatic Brain Injury Rehabilitation. Brain Sciences. 2023; 13: 1594.","DOI":"10.3390\/brainsci13111594"},{"key":"ref97","doi-asserted-by":"publisher","unstructured":"Gray SN. An Overview of the Use of Neurofeedback Biofeedback for the Treatment of Symptoms of Traumatic Brain Injury in Military and Civilian Populations. Medical Acupuncture. 2017; 29: 215\u2013219.","DOI":"10.1089\/acu.2017.1220"},{"key":"ref98","doi-asserted-by":"publisher","unstructured":"Calderone A, Latella D, Bonanno M, Quartarone A, Mojdehdehbaher S, Celesti A, et al. Towards Transforming Neurorehabilitation: The Impact of Artificial Intelligence on Diagnosis and Treatment of Neurological Disorders. Biomedicines. 2024; 12: 2415.","DOI":"10.3390\/biomedicines12102415"},{"key":"ref99","doi-asserted-by":"publisher","unstructured":"Huang X, Gu L, Sun J, Eils R. Bridging the gaps: Overcoming challenges of implementing AI in healthcare. Med (New York, N.Y.). 2025; 6: 100666.","DOI":"10.1016\/j.medj.2025.100666"},{"key":"ref100","doi-asserted-by":"publisher","unstructured":"Badar M, Younis R, Sikdar S, Nejdl W, Fisichella M. Fed-FUEL: fairness and utility enhancing agnostic federated learning framework. Data Mining and Knowledge Discovery. 2025; 39: 84.","DOI":"10.1007\/s10618-025-01152-0"},{"key":"ref101","doi-asserted-by":"publisher","unstructured":"Vay SU, Flitsch LJ, Rabenstein M, Rogall R, Blaschke S, Kleinhaus J, et al. The plasticity of primary microglia and their multifaceted effects on endogenous neural stem cells in vitro and in vivo. Journal of Neuroinflammation. 2018; 15: 226.","DOI":"10.1186\/s12974-018-1261-y"},{"key":"ref102","doi-asserted-by":"publisher","unstructured":"Zhang H, Li CL, Qu Y, Yang YX, Du J, Zhao Y. Effects and neuroprotective mechanisms of vagus nerve stimulation on cognitive impairment with traumatic brain injury in animal studies: A systematic review and meta-analysis. Frontiers in Neurology. 2022; 13: 963334.","DOI":"10.3389\/fneur.2022.963334"},{"key":"ref103","doi-asserted-by":"publisher","unstructured":"Daines SA. The Therapeutic Potential and Limitations of Ketones in Traumatic Brain Injury. Frontiers in Neurology. 2021; 12: 723148.","DOI":"10.3389\/fneur.2021.723148"},{"key":"ref104","doi-asserted-by":"publisher","unstructured":"Wilson L, Stewart W, Dams-O'Connor K, Diaz-Arrastia R, Horton L, Menon DK, et al. The chronic and evolving neurological consequences of traumatic brain injury. The Lancet. Neurology. 2017; 16: 813\u2013825.","DOI":"10.1016\/S1474-4422(17)30279-X"},{"key":"ref105","doi-asserted-by":"publisher","unstructured":"Bodien YG, McCrea M, Dikmen S, Temkin N, Boase K, Machamer J, et al. Optimizing Outcome Assessment in Multicenter TBI Trials: Perspectives From TRACK-TBI and the TBI Endpoints Development Initiative. The Journal of Head Trauma Rehabilitation. 2018; 33: 147\u2013157.","DOI":"10.1097\/HTR.0000000000000367"},{"key":"ref106","doi-asserted-by":"publisher","unstructured":"MacLean MA, Muradov JH, Greene R, Van Hameren G, Clarke DB, Dreier JP, et al. Memantine inhibits cortical spreading depolarization and improves neurovascular function following repetitive traumatic brain injury. Science Advances. 2023; 9: eadj2417.","DOI":"10.1126\/sciadv.adj2417"},{"key":"ref107","doi-asserted-by":"publisher","unstructured":"Li ZM, Xiao YL, Zhu JX, Geng FY, Guo CJ, Chong ZL, et al. Recombinant human erythropoietin improves functional recovery in patients with severe traumatic brain injury: A randomized, double blind and controlled clinical trial. Clinical Neurology and Neurosurgery. 2016; 150: 80\u201383.","DOI":"10.1016\/j.clineuro.2016.09.001"},{"key":"ref108","doi-asserted-by":"publisher","unstructured":"Ghaith HS, Nawar AA, Gabra MD, Abdelrahman ME, Nafady MH, Bahbah EI, et al. A Literature Review of Traumatic Brain Injury Biomarkers. Molecular Neurobiology. 2022; 59: 4141\u20134158.","DOI":"10.1007\/s12035-022-02822-6"},{"key":"ref109","doi-asserted-by":"publisher","unstructured":"Thelin EP, Zeiler FA, Ercole A, Mondello S, B\u00fcki A, Bellander BM, et al. Serial Sampling of Serum Protein Biomarkers for Monitoring Human Traumatic Brain Injury Dynamics: A Systematic Review. Frontiers in Neurology. 2017; 8: 300.","DOI":"10.3389\/fneur.2017.00300"},{"key":"ref110","doi-asserted-by":"publisher","unstructured":"Carpenter KLH, Jalloh I, Hutchinson PJ. Glycolysis and the significance of lactate in traumatic brain injury. Frontiers in Neuroscience. 2015; 9: 112.","DOI":"10.3389\/fnins.2015.00112"},{"key":"ref111","doi-asserted-by":"publisher","unstructured":"Burke E, Cramer SC. Biomarkers and predictors of restorative therapy effects after stroke. Current Neurology and Neuroscience Reports. 2013; 13: 329.","DOI":"10.1007\/s11910-012-0329-9"},{"key":"ref112","doi-asserted-by":"publisher","unstructured":"PRACTICAL, PANTHER, TRAITS, INCEPT, and REMAP-CAP investigators. The Rise of Adaptive Platform Trials in Critical Care. American Journal of Respiratory and Critical Care Medicine. 2024; 209: 491\u2013496.","DOI":"10.1164\/rccm.202401-0101CP"},{"key":"ref113","doi-asserted-by":"publisher","unstructured":"Nelson LD, Ranson J, Ferguson AR, Giacino J, Okonkwo DO, Valadka AB, et al. Validating Multi-Dimensional Outcome Assessment Using the Traumatic Brain Injury Common Data Elements: An Analysis of the TRACK-TBI Pilot Study Sample. Journal of Neurotrauma. 2017; 34: 3158\u20133172.","DOI":"10.1089\/neu.2017.5139"}],"container-title":["Frontiers in Bioscience-Landmark"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/31\/8\/10.31083\/FBL48402","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T12:36:04Z","timestamp":1788438964000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/31\/8\/10.31083\/FBL48402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,18]]},"references-count":113,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026]]}},"alternative-id":["S2768-6701(26)02067-8"],"URL":"https:\/\/doi.org\/10.31083\/fbl48402","relation":{},"ISSN":["2768-6701","2768-6698"],"issn-type":[{"value":"2768-6701","type":"print"},{"value":"2768-6698","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,18]]},"article-number":"48402"}}